NCT04918329

Brief Summary

Functional digestive pathologies are defined by symptoms such as functional dyspepsia, gastroesophageal reflux, irritable bowel syndrome, gastroesophageal reflux, functional constipation, functional diarrhea, functional bloating, the opioid-induced constipation and fecal incontinence, without organic substratum. These diseases are very common in the general population (20%) and represent the first cause of consultation in city gastroenterology. The pathophysiology of these functional disorders is complex and often multifactorial: disturbances in digestive motility, altered visceral sensitivity, sphincter dysfunction, post-surgery, intestinal inflammation, dysbiosis, and impairment of the gut-brain axis. For example, it has been shown that one in four patients with inflammatory bowel disease in confirmed remission report digestive symptoms consistent with a functional bowel disorder, suggesting a possible pathophysiological continuum between these two conditions. The objective of this study is to collect prospective clinical and tests data and a biological collection from biological samples (digestive biopsies, blood, urine and fecal samples) collected as part of the standard care. This collection could identify diagnostic or prognostic markers of the therapeutic response.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
54mo left

Started Oct 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress56%
Oct 2020Oct 2030

Study Start

First participant enrolled

October 9, 2020

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

May 27, 2021

Completed
12 days until next milestone

First Posted

Study publicly available on registry

June 8, 2021

Completed
9.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 9, 2030

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 9, 2030

Last Updated

January 8, 2026

Status Verified

December 1, 2025

Enrollment Period

10 years

First QC Date

May 27, 2021

Last Update Submit

January 5, 2026

Conditions

Keywords

Observatoryfunctional digestive disorders

Outcome Measures

Primary Outcomes (1)

  • Functional digestive explorations

    Gastrointestinal intraluminal pressures (mmHg), recorded during gastrointestinal manometry.

    10 years

Secondary Outcomes (45)

  • Radiological findings

    10 years

  • Clinical data of patients with functional digestive disorders

    10 years

  • Gastric emptying study

    10 years

  • EndoFLIP system

    10 years

  • Rectal barostat

    10 years

  • +40 more secondary outcomes

Interventions

Non interventional study

Also known as: Non interventional study

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with functional digestive disorders consulting in our centre functional digestive disorders whether or not they are sequelae of an organic pathology.

You may qualify if:

  • Patients over 18 years of age;
  • Patients with functional digestive disorder for more of 3 months;
  • Patients assessed as part of routine care;
  • Patients affiliated to the Social Security ;
  • Patients not opposed to participation in the Centre

You may not qualify if:

  • Person deprived of liberty by administrative or judicial decision or major protected subject (under guardianship or curatorship);
  • Patients unable for any reason to read, understand, respond questionnaires (visual, psychiatric, cognitive, etc.)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Physiology Unit, Hopital Charles Nicolle, 1 rue de Germont

Rouen, 76031, France

RECRUITING

Related Publications (2)

  • Soliman H, Wuestenberghs F, Desprez C, Leroi AM, Melchior C, Gourcerol G. Physiological characterization of gastric emptying using high-resolution antropyloroduodenal manometry. Am J Physiol Gastrointest Liver Physiol. 2024 Jan 1;326(1):G16-G24. doi: 10.1152/ajpgi.00101.2023. Epub 2023 Oct 24.

  • Gourcerol G, Melchior C, Wuestenberghs F, Desprez C, Prevost G, Grosjean J, Leroi AM, Tavolacci MP. Delayed gastric emptying as an independent predictor of mortality in gastroparesis. Aliment Pharmacol Ther. 2022 Apr;55(7):867-875. doi: 10.1111/apt.16827. Epub 2022 Feb 20.

Biospecimen

Retention: SAMPLES WITH DNA

Blood, fecaes, biopsies, urine,

MeSH Terms

Conditions

Irritable Bowel SyndromeDyspepsiaEncopresisAbdominal Pain

Interventions

Observation

Condition Hierarchy (Ancestors)

Colonic Diseases, FunctionalColonic DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System DiseasesSigns and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and SymptomsBehavioral SymptomsBehaviorElimination DisordersMental DisordersPainNeurologic Manifestations

Intervention Hierarchy (Ancestors)

MethodsInvestigative Techniques

Central Study Contacts

Anne-Marie AL LEROI, Professor

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
10 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 27, 2021

First Posted

June 8, 2021

Study Start

October 9, 2020

Primary Completion (Estimated)

October 9, 2030

Study Completion (Estimated)

October 9, 2030

Last Updated

January 8, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

No sharing plan

Locations